Stock Price
P/E Ratio
Volume Traded Today
Dividend
52 Week High/low
Mesa Laboratories Inc Market Cap
The Mesa Laboratories Inc (MLAB) share price is expected to increase by 9.71% over the next year. This is based on calculating the average 12-month share price estimate provided by 2 stock analysts who have covered MLAB. Price targets range from $120 at the low end to $160 at the high end. The current analyst consensus for MLAB is a buy. Please note analyst price targets are not guaranteed and could be missed completely.
About 2 Wall Street analysts have assignedMLAB 1 buy ratings, 1 hold ratings, and 0 sell ratings. This means that analysts expect Mesa Laboratories Inc to hold. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on MLAB. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.
These are the latest 20 analyst ratings of MLAB.
|
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
|---|---|---|---|---|
| Vijay Kumar Evercore ISI Group | Outperform | $160 | Maintains | Oct 1, 2024 |
| Brandon Couillard Wells Fargo | Underweight | $120 | Initiates | Aug 27, 2024 |
| Vijay Kumar Evercore ISI Group | Outperform | $120 | Maintains | Aug 6, 2024 |
| Vijay Kumar Evercore ISI Group | Outperform | $106 | Maintains | Jul 2, 2024 |
| Vijay Kumar Evercore ISI Group | Outperform | $130 | Maintains | Apr 4, 2024 |
| Vijay Kumar Evercore ISI Group | Outperform | $125 | Upgrade | Jan 4, 2024 |
| Vijay Kumar Evercore ISI Group | In-Line | $300 | Downgrade | Jan 4, 2021 |
KeyBanc | Sector Weight | Initiates | Nov 10, 2020 | |
Keybanc | Sector Weight | Initiates | Nov 10, 2020 | |
JP Morgan | Neutral | Initiates | Oct 2, 2020 | |
Jefferies | Buy | Initiates | Dec 4, 2019 | |
Evercore ISI Group | Outperform | Initiates | Aug 26, 2019 | |
Sidoti & Co. | Neutral | Downgrade | Jun 10, 2016 | |
Janney Montgomery Scott | Buy | Initiates | Feb 10, 2016 | |
Janney Capital | Buy | Initiates | Feb 10, 2016 |
When did it IPO
1995
Staff Count
736
Country
United States
Sector/Industry
Technology/Scientific & Technical Instruments
CEO
Mr. Gary M. Owens
Market Cap
$721.0M
In 2023, MLAB generated $219.1M in revenue, which was a increase of 18.85% from the previous year. This can be seen as a signal that MLAB's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Mon, 26 Aug 2024
Sentiment - POSITIVE
Source - Zacks Investment Research
Summary - Mesa Labs (MLAB) shares are gaining momentum, supported by positive earnings estimate revisions, suggesting potential for continued upward movement.
Why It Matters - Rising earnings estimates for Mesa Labs suggest strong financial performance ahead, potentially driving share prices higher and attracting investor interest.
Mon, 26 Aug 2024
Sentiment - POSITIVE
Source - Zacks Investment Research
Summary - Mesa Labs (MLAB) has been upgraded to a Zacks Rank #1 (Strong Buy), indicating increased optimism about its earnings prospects, which may drive its stock price higher.
Why It Matters - Mesa Labs' upgrade to a Zacks Rank #1 signals strong earnings potential, indicating positive momentum that could attract more investors and drive the stock price higher.
Mon, 26 Aug 2024
Sentiment - POSITIVE
Source - Zacks Investment Research
Summary - QFIN, GHM, CRNC, SUPV, and MLAB are now on the Zacks Rank #1 (Strong Buy) List as of August 26, 2024.
Why It Matters - The addition of QFIN, GHM, CRNC, SUPV, and MLAB to the Zacks Rank #1 (Strong Buy) List indicates strong potential for stock performance, attracting investors seeking high-return opportunities.
Mon, 05 Aug 2024
Sentiment - NEUTRAL
Source - GlobeNewsWire
Summary - Mesa Laboratories, Inc. (NASDAQ:MLAB) reported its 1Q25 financial results for the period ending June 30, 2024. Details on performance metrics were disclosed in the announcement.
Why It Matters - Mesa Laboratories' quarterly results can impact stock performance, affecting investor sentiment and potentially influencing market trends in life sciences and quality control sectors.
Mon, 08 Jul 2024
Sentiment - NEUTRAL
Source - GlobeNewsWire
Summary - Mesa Laboratories, Inc. (NASDAQ: MLAB) declared a quarterly dividend of $0.16 per share, payable on September 16, 2024, to shareholders on record by August 30, 2024.
Why It Matters - Mesa Laboratories' declaration of a quarterly dividend signals financial stability and a commitment to returning value to shareholders, potentially attracting income-focused investors and boosting stock demand.
Wed, 05 Jun 2024
Sentiment - NEUTRAL
Source - GlobeNewsWire
Summary - Mesa Laboratories, Inc. (NASDAQ:MLAB) reported its 4Q24 and FY24 results, ending March 31, 2024. Further details on financial performance were released.
Why It Matters - Mesa Laboratories' quarterly and annual results can signal financial health and growth potential, impacting stock performance and investor sentiment.
The information that Ticker Nerd provides is general in nature as it has been prepared without taking account of your objectives, financial situation or needs. It is not intended as legal, financial or investment advice and should not be construed or relied on as such. Ticker Nerd is for information purposes only. Ticker Nerd is not responsible for any damages or losses that may occur as a result of reliance on this information. Before making any commitment of a legal or financial nature you should seek advice from a qualified and registered legal practitioner or financial or investment adviser. All content, group, messaging, tweets, newsletter, article, and email created by Ticker Nerd is intended for educational and information purposes only, is not financial, investment, legal or tax advice, and is a restatement, summary or extract of other data and research reports that are widely distributed from sources such as, but not limited to, Bloomberg, Market Watch, Wall Street Journal, Google Finance, and Yahoo Finance. Ticker Nerd is not a registered financial, investment, legal or tax advisor and is not liable for any financial loss you may incur acting on any information provided by Ticker Nerd. By registering, you agree not to hold Ticker Nerd liable at any time or under any circumstances for your decisions, actions, or results.
